CoChat

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

Open access
Sasso, Ferdinando Carlo, Simeon, Vittorio, Galiero, Raffaele, Caturano, Alfredo, De Nicola, Luca, Chiodini, Paolo, Rinaldi, Luca, Salvatore, Teresa, Lettieri, Miriam, Nevola, Riccardo, Sardu, Celestino, Docimo, Giovanni, Loffredo, Giuseppe, Marfella, Raffaele, Adinolfi, Luigi Elio, Minutolo, Roberto, NID-2 study group Investigators, Amelia, U, Acierno, C, Calatola, P, Carbonara, O, Conte, G, Corigliano, G, Corigliano, M, D’Urso, R, De Matteo, A, De Nicola, L, De Rosa, N, Del Vecchio, E, Di Giovanni, G, Gatti, A, Gentile, S, Gesuè, L, Improta, L, LampitellaJr, A, Lampitella, A, Lanzilli, A, Lascar, N, Masi, S, Mattei, P, Mastrilli, V, Memoli, P, Minutolo, R, Nasti, R, Pagano, A, Pentangelo, M, Pisa, E, Rossi, E, Sasso, F C, Sorrentino, S, Torella, R, Troise, R, Trucillo, P, Turco, A A, Turco, S, Zibella, F, Zirpoli, L · 2022 · Cardiovascular Diabetology
Cited by 72

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Background: Nephropathy in Diabetes type 2 (NID-2) study is an open-label cluster randomized clinical trial that demonstrated that multifactorial intensive treatment reduces Major Adverse Cardiac Events (MACEs) and overall mortality versus standard of care in type 2 diabetic subjects with albuminuria and no history of cardiovascular disease. Aim of the present post-hoc analysis of NID- 2 study is to evaluate whether the number of risk factors on target associates with patient outcomes. Methods: Intervention phase lasted four years and subsequent follow up for survival lasted 10 years. To the aim of this post-hoc analysis, the whole population has been divided into 3 risk groups: 0–1 risk factor (absent/low); 2–3 risk factors (intermediate); 4 risk factors (high). Primary endpoint was a composite of fatal and non-fatal MACEs, the secondary endpoint was all-cause death at the end of the follow-up phase. Results: Absent/low risk group included 166 patients (52.4%), intermediate risk group 128 (40.4%) and high-risk group 23 (7.3%). Cox model showed a significant higher risk of MACE and death in the high-risk group after adjustment for confounding variables, including treatment arm (HR 1.91, 95% CI 1.04–3.52, P = 0.038 and 1.96, 95%CI 1.02–3.8, P = 0,045, respectively, vs absent/low risk group). Conclusions: This post-hoc analysis of the NID-2 trial indicates that the increase in the number of risk factors at target correlates with better cardiovascular-free survival in patients with type 2 diabetes at high CV risk. Clinical Trial Registration: ClinicalTrials.gov number, NCT00535925. https://clinicaltrials.gov/ct2/show/NCT00535925

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-022-01674-7

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 72

Metadata

Authors
Sasso, F. C., Simeon, V., Galiero, R., Caturano, A., De Nicola, L., Chiodini, P., Rinaldi, L., Salvatore, T., Lettieri, M., Nevola, R., Sardu, C., Docimo, G., Loffredo, G., Marfella, R., Adinolfi, L. E., Minutolo, R., NID-2 study group Investigators, Amelia, U., Acierno, C., Calatola, P., Carbonara, O., Conte, G., Corigliano, G., Corigliano, M., D’Urso, R., De Matteo, A., De Nicola, L., De Rosa, N., Del Vecchio, E., Di Giovanni, G., Gatti, A., Gentile, S., Gesuè, L., Improta, L., LampitellaJr, A., Lampitella, A., Lanzilli, A., Lascar, N., Masi, S., Mattei, P., Mastrilli, V, Memoli, P., Minutolo, R., Nasti, R., Pagano, A., Pentangelo, M., Pisa, E., Rossi, E., Sasso, F. C., Sorrentino, S., Torella, R., Troise, R., Trucillo, P., Turco, A. A., Turco, S., Zibella, F., & Zirpoli, L.
Venue
Cardiovascular Diabetology
Published
2022-11-07
Volume
21
Issue
1
Pages
235-235
ISSN
1475-2840 (ISSN-L)
OpenAlex
W4308411225
Cited by
72
References
12
FWCI
9.32
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial. https://app.cochat.ai/papers/10.1186/s12933-022-01674-7
The paper
Sasso, F. C., Simeon, V., Galiero, R., Caturano, A., De Nicola, L., Chiodini, P., Rinaldi, L., Salvatore, T., Lettieri, M., Nevola, R., Sardu, C., Docimo, G., Loffredo, G., Marfella, R., Adinolfi, L. E., Minutolo, R., NID-2 study group Investigators, Amelia, U., Acierno, C., . . . Zirpoli, L. (2022). The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-022-01674-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.